Bausch & Lomb (BLCO) Common Equity (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Common Equity came in at $6.4 billion in Q2 2026, down 0.98% YoY from $6.5 billion in Q2 2025, and little changed on a QoQ basis from $6.5 billion in Q1 2026.
Bausch & Lomb (BLCO) Common Equity (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Common Equity data on file, last reported at $6.4 billion in Q2 2026.
- Quarterly Common Equity fell 0.98% year-over-year to $6.4 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $6.4 billion (down 0.98% YoY) and the FY2025 annual result came in at $6.5 billion, changed 0.38% from the prior year.
- Common Equity was little changed at $6.4 billion in Q2 2026, from $6.5 billion in the prior quarter.
- In the past five years, Common Equity ranged from a high of $7.2 billion in Q1 2022 to a low of $6.4 billion in Q1 2025.
- A 5-year average of $6.7 billion and a median of $6.7 billion in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity declined 28.51% — and 2023, when it increased 1.3%.
- Tracing BLCO's Common Equity over 5 years: stood at $7.1 billion in 2022, then dropped by 2.55% to $6.9 billion in 2023, then fell by 5.43% to $6.5 billion in 2024, then slipped by 0.38% to $6.5 billion in 2025, then retreated by 1.15% to $6.4 billion in 2026.
- The last three Common Equity figures came in at $6.4 billion (Q2 2026), $6.5 billion (Q1 2026), and $6.5 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 133.22 Bn | 128.00 Bn | 1.96 Bn | 18.30 Bn |
| 2 | Becton Dickinson | 52.16 Bn | 51.30 Bn | 2.32 Bn | 24.42 Bn |
| 3 | Alcon | 35.49 Bn | 34.13 Bn | 1.68 Bn | 21.60 Bn |
| 4 | Resmed | 33.48 Bn | 32.01 Bn | 861.22 Mn | 6.59 Bn |
| 5 | Medline | 28.58 Bn | 25.90 Bn | 2.22 Bn | 19.08 Bn |
| 6 | West Pharmaceutical Services | 24.97 Bn | 24.53 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Solventum | 15.28 Bn | 14.88 Bn | 1.29 Bn | 4.80 Bn |
| 8 | Cooper Companies | 14.81 Bn | 14.67 Bn | 735.40 Mn | 8.24 Bn |
| 9 | Baxter International | 13.60 Bn | 11.45 Bn | 1.03 Bn | 6.21 Bn |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn | 6.44 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.44 Bn |
| Mar 31, 2026 | 6.45 Bn |
| Dec 31, 2025 | 6.52 Bn |
| Sep 30, 2025 | 6.50 Bn |
| Jun 30, 2025 | 6.51 Bn |
| Mar 31, 2025 | 6.43 Bn |
| Dec 31, 2024 | 6.54 Bn |
| Sep 30, 2024 | 6.66 Bn |
| Jun 30, 2024 | 6.58 Bn |
| Mar 31, 2024 | 6.73 Bn |
| Dec 31, 2023 | 6.92 Bn |
| Sep 30, 2023 | 6.88 Bn |
| Jun 30, 2023 | 7.03 Bn |
| Mar 31, 2023 | 7.05 Bn |
| Dec 31, 2022 | 7.10 Bn |
| Sep 30, 2022 | 6.80 Bn |
| Jun 30, 2022 | 6.97 Bn |
| Mar 31, 2022 | 7.22 Bn |
| Dec 31, 2021 | 9.40 Bn |
| Sep 30, 2021 | 9.39 Bn |